These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 15878634)

  • 1. Bacterial ghosts as antigen delivery vehicles.
    Mayr UB; Walcher P; Azimpour C; Riedmann E; Haller C; Lubitz W
    Adv Drug Deliv Rev; 2005 Jun; 57(9):1381-91. PubMed ID: 15878634
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antigen discovery and delivery of subunit vaccines by nonliving bacterial ghost vectors.
    Walcher P; Mayr UB; Azimpour-Tabrizi C; Eko FO; Jechlinger W; Mayrhofer P; Alefantis T; Mujer CV; DelVecchio VG; Lubitz W
    Expert Rev Vaccines; 2004 Dec; 3(6):681-91. PubMed ID: 15606353
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bacterial ghosts as carrier and targeting systems for mucosal antigen delivery.
    Jalava K; Eko FO; Riedmann E; Lubitz W
    Expert Rev Vaccines; 2003 Feb; 2(1):45-51. PubMed ID: 12901596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bacterial ghosts as adjuvant particles.
    Riedmann EM; Kyd JM; Cripps AW; Lubitz W
    Expert Rev Vaccines; 2007 Apr; 6(2):241-53. PubMed ID: 17408373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bacterial ghosts: non-living candidate vaccines.
    Szostak MP; Hensel A; Eko FO; Klein R; Auer T; Mader H; Haslberger A; Bunka S; Wanner G; Lubitz W
    J Biotechnol; 1996 Jan; 44(1-3):161-70. PubMed ID: 8717400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Bacterial ghosts as multifunctional vaccine particles.
    Szostak MP; Mader H; Truppe M; Kamal M; Eko FO; Huter V; Marchart J; Jechlinger W; Haidinger W; Brand E; Denner E; Resch S; Dehlin E; Katinger A; Kuen B; Haslberger A; Hensel A; Lubitz W
    Behring Inst Mitt; 1997 Feb; (98):191-6. PubMed ID: 9382740
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Current status and future perspectives of DNA vaccine delivery by attenuated intracellular bacteria.
    Dietrich G
    Arch Immunol Ther Exp (Warsz); 2000; 48(3):177-82. PubMed ID: 10912622
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mucosal vaccine delivery of antigens tightly bound to an adjuvant particle made from food-grade bacteria.
    van Roosmalen ML; Kanninga R; El Khattabi M; Neef J; Audouy S; Bosma T; Kuipers A; Post E; Steen A; Kok J; Buist G; Kuipers OP; Robillard G; Leenhouts K
    Methods; 2006 Feb; 38(2):144-9. PubMed ID: 16414272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of different live vaccine strategies in vivo for delivery of protein antigen or antigen-encoding DNA and mRNA by virulence-attenuated Listeria monocytogenes.
    Loeffler DI; Schoen CU; Goebel W; Pilgrim S
    Infect Immun; 2006 Jul; 74(7):3946-57. PubMed ID: 16790768
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bacterial ghosts as a novel advanced targeting system for drug and DNA delivery.
    Paukner S; Stiedl T; Kudela P; Bizik J; Al Laham F; Lubitz W
    Expert Opin Drug Deliv; 2006 Jan; 3(1):11-22. PubMed ID: 16370937
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Bacterial Ghost platform system: production and applications.
    Langemann T; Koller VJ; Muhammad A; Kudela P; Mayr UB; Lubitz W
    Bioeng Bugs; 2010; 1(5):326-36. PubMed ID: 21326832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bacterial ghosts (BGs)--advanced antigen and drug delivery system.
    Kudela P; Koller VJ; Lubitz W
    Vaccine; 2010 Aug; 28(36):5760-7. PubMed ID: 20619379
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary delivery of DNA encoding Mycobacterium tuberculosis latency antigen Rv1733c associated to PLGA-PEI nanoparticles enhances T cell responses in a DNA prime/protein boost vaccination regimen in mice.
    Bivas-Benita M; Lin MY; Bal SM; van Meijgaarden KE; Franken KL; Friggen AH; Junginger HE; Borchard G; Klein MR; Ottenhoff TH
    Vaccine; 2009 Jun; 27(30):4010-7. PubMed ID: 19389445
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial ghosts as vaccine candidates for veterinary applications.
    Jalava K; Hensel A; Szostak M; Resch S; Lubitz W
    J Control Release; 2002 Dec; 85(1-3):17-25. PubMed ID: 12480307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bacterial ghosts as a delivery system for zona pellucida-2 fertility control vaccines for brushtail possums (Trichosurus vulpecula).
    Walcher P; Cui X; Arrow JA; Scobie S; Molinia FC; Cowan PE; Lubitz W; Duckworth JA
    Vaccine; 2008 Dec; 26(52):6832-8. PubMed ID: 18948157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bacterial ghosts as adjuvants: mechanisms and potential.
    Hajam IA; Dar PA; Won G; Lee JH
    Vet Res; 2017 Jun; 48(1):37. PubMed ID: 28645300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bacterial ghosts--biological particles as delivery systems for antigens, nucleic acids and drugs.
    Tabrizi CA; Walcher P; Mayr UB; Stiedl T; Binder M; McGrath J; Lubitz W
    Curr Opin Biotechnol; 2004 Dec; 15(6):530-7. PubMed ID: 15560979
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Potentiation of an anthrax DNA vaccine with electroporation.
    Luxembourg A; Hannaman D; Nolan E; Ellefsen B; Nakamura G; Chau L; Tellez O; Little S; Bernard R
    Vaccine; 2008 Sep; 26(40):5216-22. PubMed ID: 18462850
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Applications of bacterial ghosts in biomedicine.
    Lubitz P; Mayr UB; Lubitz W
    Adv Exp Med Biol; 2009; 655():159-70. PubMed ID: 20047041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial ghosts as carriers of protein subunit and DNA-encoded antigens for vaccine applications.
    Muhammad A; Champeimont J; Mayr UB; Lubitz W; Kudela P
    Expert Rev Vaccines; 2012 Jan; 11(1):97-116. PubMed ID: 22149712
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.